Why the FDA Still Can't Explain the Baby Botulism Outbreak

The FDA's investigation into a botulism outbreak that sickened 48 infants across 17 states successfully traced contamination through the supply chain but failed to identify the root cause or how to prevent future incidents. With three companies at the center of the outbreak each deflecting responsibility, accountability remains unclear and potential preventive measures are lacking. This gap exposes critical vulnerabilities in food safety oversight, particularly for the vulnerable infant population dependent on formula for survival.